SpineVision has announced that it has expanded its dynamic stabilisation platform portfolio with the addition of the pre-bent Flex+2 for use in hybrid cases and that it has received regulatory approval to market its Flex+2 products in Brazil. Earlier this year, the company started selling its new-generation Flex+2 dynamic and hybrid stabilisation rod in Europe.
A press release reports that further to the portfolio expansion and approval in Brazil, 510(k) approval has been granted in the USA for a range of SpineVision’s surgical instrumentation focused on a minimally invasive approach to treating conditions related to ageing and degeneration of the spine.
“We are extremely pleased with the expansion of our product offerings and with the number of markets in which we have now established a considerable sales presence. These factors are driving our double-digit sales growth. Not only are we selling our products in the USA and Europe, but also we now are broadening our product offerings and presence in South America and especially Brazil, where there is significant opportunity for SpineVision,” said Arnaud Brisard, chief executive officer.
